Magnesium pyridoxal 5-phosphate glutamate
From Self-sufficiency
Revision as of 16:26, 29 July 2010 by PotatoBot (Talk) (Stub sorting and placement of stub template(s))
File:Magnesium pyridoxal 5-phosphate glutamate.png | |
Identifiers | |
---|---|
CAS Number | 62055-05-4 |
ATC code | C10AX07 (WHO) |
PubChem | CID 173846 |
Magnesium pyridoxal 5-phosphate glutamate (trade name Sedalipid) is a hypolipidemic agent.[1]
References
- ↑ Schuitemaker GE, van der Pol GA, Aretz CP, Dinant GJ (2001). "A placebo-controlled, double-blind, randomised trial of magnesium-pyridoxal-5'-phosphate-glutamate for hypercholesterolaemia and other clinical-chemical risk factors of cardiovascular disease in a primary care setting". Eur. J. Clin. Pharmacol. 56 (12): 857–63. doi:10.1007/s002280000247. PMID 11317472.
30px | This drug article relating to the cardiovascular system is a stub. You can help ssf by expanding it. |
Categories:
- Pages with script errors
- CS1 maint: Multiple names: authors list
- Pages with broken file links
- Articles which use infobox templates with no data rows
- Infobox drug tracked parameters
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- 2Fix
- Hypolipidemic agents
- Cardiovascular system drug stubs